About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tarm1tm1Yiw
targeted mutation 1, Yoichiro Iwakura
MGI:6509631
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Tarm1tm1Yiw/Tarm1tm1Yiw involves: C57BL/6 * C57BL/6NSlc MGI:6509975


Genotype
MGI:6509975
hm1
Allelic
Composition
Tarm1tm1Yiw/Tarm1tm1Yiw
Genetic
Background
involves: C57BL/6 * C57BL/6NSlc
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tarm1tm1Yiw mutation (0 available); any Tarm1 mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
• mice show decreased susceptibility to collagen-induced arthritis (CIA), showing reduced incidence of arthritis and reduced severity score, decreased synovial inflammation, decreased pannus formation, and decreased cartilage and bone destruction in joints

immune system
N
• mice show no obvious abnormalities up to 1 year of age under specific pathogen-free conditions and immune cell compositions in lymph nodes, spleen, and bone marrow are normal
• bone marrow cells treated with granulocyte/macro-phage colony-stimulating factor (GM-CSF) show a lower proportion of the I-A/I-EhiCD11c+ cell population than treated wild-type cells, indicating impaired maturation of dendritic cells
• the proportion of CD11c+ cell in total lymph node cells is decreased only slightly after CIA induction
• the proportion of I-A/I-E+CD11c+ mature dendritic cells in total CD11c+ dendritic cells is lower after CIA induction
• mice with CIA show reduced B cell (CD19+) population in inguinal lymph nodes
• mice with CIA show reduced activated CD4+ T cell (CD44+CD4+) population in inguinal lymph nodes
• proliferative response of draining lymph node cells to type 2 collagen is suppressed in CIA mice
• when mutant granulocyte/macrophage colony-stimulating factor-induced dendrtitic cells are cocultured with CD4+ T cells from OT-II mice, T cell proliferative response to OVA is decreased
• however, proliferative responses of T and B cells are similar to wild-type upon stimulation with anti-CD3 and anti-IgM antibodies, respectively and differentiation of CD4+ T cells to regulatory T, Th1 and Th17 cells is normal
• type 2 collagen-specific serum IgG2a concentrations are reduced in mice with collagen-induced arthritis
• type 2 collagen-specific serum IgG2b concentrations are reduced in mice with collagen-induced arthritis
• type 2 collagen-specific serum IgG3 concentrations are reduced in mice with collagen-induced arthritis
• dendritic cells show impaired antigen-presenting ability following CIA
• T cell responses against type 2 collagen antibodies are greatly reduced in co-culture with mutant dendritic cells, suggesting that antigen-presenting ability of dendritic cells is impaired
• antigen-presenting ability of granulocyte/macrophage colony-stimulating factor (GM-CSF)-induced dendrtitic cells from bone marrow cells is impaired
• concentration of IFN-gamma in culture supernatant from lymph cell culture is lower after collagen-induced arthritis induction
• concentration of IL-17A in culture supernatant from lymph cell culture is lower after collagen-induced arthritis induction
• IL-6 production is reduced in bone marrow neutrophils following stimulation with LPS and zymosan
• IL-6 production is enhanced in bone marrow neutrophils after CpG treatment
• TNF production is reduced in bone marrow neutrophils upon stimulation with zymosan and M. Tuberculosis
• TNF production is enhanced in bone marrow neutrophils after CpG treatment
• concentration of TNF in culture supernatant from lymph cell culture is lower after collagen-induced arthritis induction
• mice show decreased susceptibility to collagen-induced arthritis (CIA), showing reduced incidence of arthritis and reduced severity score, decreased synovial inflammation, decreased pannus formation, and decreased cartilage and bone destruction in joints

hematopoietic system
• bone marrow cells treated with granulocyte/macro-phage colony-stimulating factor (GM-CSF) show a lower proportion of the I-A/I-EhiCD11c+ cell population than treated wild-type cells, indicating impaired maturation of dendritic cells
• the proportion of CD11c+ cell in total lymph node cells is decreased only slightly after CIA induction
• the proportion of I-A/I-E+CD11c+ mature dendritic cells in total CD11c+ dendritic cells is lower after CIA induction
• mice with CIA show reduced B cell (CD19+) population in inguinal lymph nodes
• mice with CIA show reduced activated CD4+ T cell (CD44+CD4+) population in inguinal lymph nodes
• proliferative response of draining lymph node cells to type 2 collagen is suppressed in CIA mice
• when mutant granulocyte/macrophage colony-stimulating factor-induced dendrtitic cells are cocultured with CD4+ T cells from OT-II mice, T cell proliferative response to OVA is decreased
• however, proliferative responses of T and B cells are similar to wild-type upon stimulation with anti-CD3 and anti-IgM antibodies, respectively and differentiation of CD4+ T cells to regulatory T, Th1 and Th17 cells is normal
• type 2 collagen-specific serum IgG2a concentrations are reduced in mice with collagen-induced arthritis
• type 2 collagen-specific serum IgG2b concentrations are reduced in mice with collagen-induced arthritis
• type 2 collagen-specific serum IgG3 concentrations are reduced in mice with collagen-induced arthritis

cellular
• bone marrow cells treated with granulocyte/macro-phage colony-stimulating factor (GM-CSF) show a lower proportion of the I-A/I-EhiCD11c+ cell population than treated wild-type cells, indicating impaired maturation of dendritic cells
• when mutant granulocyte/macrophage colony-stimulating factor-induced dendrtitic cells are cocultured with CD4+ T cells from OT-II mice, T cell proliferative response to OVA is decreased
• however, proliferative responses of T and B cells are similar to wild-type upon stimulation with anti-CD3 and anti-IgM antibodies, respectively and differentiation of CD4+ T cells to regulatory T, Th1 and Th17 cells is normal





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory